Holen Sie sich die Stockscreener-App
3.7509
0.16%
0.0109
Schlusskurs vom Vortag:
$3.74
Offen:
$3.77
24-Stunden-Volumen:
210.30K
Relative Volume:
0.13
Marktkapitalisierung:
$519.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-10.72
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
-8.86%
1M Leistung:
+1.24%
6M Leistung:
+98.20%
1J Leistung:
+120.35%
1-Tages-Spanne:
$3.65
$3.95
1-Wochen-Bereich:
$3.63
$4.265
52-Wochen-Spanne:
$1.27
$4.86
Compass Therapeutics Inc Stock (CMPX) Company Profile
Firmenname
Compass Therapeutics Inc
Sektor
Branche
Telefon
617-500-8099
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie CMPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.755 | 641.68M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.50 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.98 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.29 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-02 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Eingeleitet | Guggenheim | Buy |
| 2025-02-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-15 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Eingeleitet | Jefferies | Buy |
| 2023-01-27 | Eingeleitet | Stifel | Buy |
| 2022-05-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-03-15 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-01-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Raymond James | Outperform |
| 2021-12-20 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-15 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
How to interpret RSI for Compass Therapeutics Inc. stockMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
Compass Therapeutics to Participate in Upcoming November Investor Events - GlobeNewswire
How Compass Therapeutics Inc. stock performs in weak economyJuly 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Institutional investors in Compass Therapeutics, Inc. (NASDAQ:CMPX) lost 9.0% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Can Compass Therapeutics Inc. recover in the next quarterMarket Weekly Review & Target Return Focused Picks - newser.com
Will Compass Therapeutics Inc. stock outperform growth indexesTrade Volume Report & Real-Time Sentiment Analysis - newser.com
How Compass Therapeutics Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Why Compass Therapeutics Inc. stock is seen as undervaluedJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Will Compass Therapeutics Inc. stock split attract more investorsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Is Compass Therapeutics Inc. stock recession proofJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
How Compass Therapeutics Inc. stock trades before earningsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) - Insider Monkey
How to track smart money flows in Compass Therapeutics Inc.Quarterly Investment Review & Weekly High Potential Alerts - newser.com
Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment - TipRanks
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):